Metrics as of 10/17/2026, 08:38 AM (Berlin time), refresh in progress.
MiniMed Group Stock
MiniMed Group, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- Country
- United States
- CEO
- Que Thanh Dallara
- Employees
- 8,000
- Market cap
- $4.9 B
- IPO
- 05/03/2026
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
MiniMed Group stock: price history
1D
-2.8%
1W
-11.3%
1M
-21.9%
6M
+21.1%
YTD
–
1Y
–
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
30/12/2026 (in 74 days)
Volatility around earnings
~50% stronger price swings than usual
Ask the agents about MiniMed Group
Analyst assessment of MiniMed Group
PRICE TARGET LOW
US$16.00
CONSENSUS
US$25.73
MEDIAN
US$28.00
PRICE TARGET HIGH
US$30.00
0
STRONG BUY
8
BUY
0
HOLD
0
SELL
0
STRONG SELL
8
TOTAL · Buy
As of: 08/10/2026
MiniMed Group stock metrics
P/E
-15.9
P/B
1.36
EV/EBITDA
28.24
RETURN ON EQUITY
0.0%
NET MARGIN
0.0%
DEBT/EQUITY
0.02
DIVIDEND YIELD
0.0%
AS OF
31/07/2026
Free float & liquidity
FREE FLOAT
9.6%
FLOAT SHARES
26,983,992
AVG. DAILY VOLUME (30D)
10,949,567
Insider transactions (SEC)
Dallara Que
Wills Courtney Nelson
Dianaty Ali
Spooner Chad
Chandrasena Gillian
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -2.8%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about MiniMed Group stock
What does MiniMed Group do?
MiniMed Group, Inc. is a company in the Healthcare sector, Medical - Equipment & Services industry, headquartered in United States.
The CEO is Que Thanh Dallara, the company employs around 8,000 people.
The IPO was on 05/03/2026; the stock trades on NASDAQ under the ticker MMED.
What do analysts say about MiniMed Group stock?
8 analysts rate the stock, the consensus is Buy (as of 08/10/2026).
The average price target is US$25.73, ranging from US$16.00 to US$30.00, with a median of US$28.00.
This is an external assessment, not a statement by Market Jury.
When does MiniMed Group report next?
The next earnings date is 30/12/2026.
Around past earnings, price swings were roughly 50% stronger than usual.
Does MiniMed Group pay a dividend?
No, MiniMed Group currently does not pay a dividend.
Which stocks are comparable to MiniMed Group?
Comparable stocks include Eli Lilly and Company, Johnson & Johnson, AbbVie, Merck &, UnitedHealth Group, Thermo Fisher Scientific, Amgen and Gilead Sciences.
How can I get MiniMed Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess MiniMed Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.